ow-dose thalidomide treatment for patients with relapsed and refractory multiple myeloma.
Not Applicable
Recruiting
- Conditions
- multiple myeloma
- Registration Number
- JPRN-UMIN000005960
- Lead Sponsor
- Gunma Hematological Disease Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients with uncontrollable infection. (2)patients with psychological diseases. (3)female who can have children. (4)patients who the doctor think unsuitable for this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method